Non-Hodgkin Lymphoma | Topics

Emergency Fertility Preservation in a Young Woman With Non-Hodgkin Lymphoma
June 19, 2021

A nulliparous woman, age 25 years, had received a diagnosis of non-Hodgkin lymphoma and now presented with stage IIA diffuse large B-cell lymphoma. Due to potential risks of chemotherapy-induced gonadotoxicity and subsequent iatrogenic premature ovarian failure and fertility loss, the patient was referred to the reproductive medicine department for fertility preservation counseling and further management.

Regardless of Prior Anti-CD20 Therapy, Axi-Cel induces Durable Antitumor Activity in FL and MZL
June 15, 2021

CAR T-cell therapy with axicabtagene ciloleucel (axi-cel; Yescarta) showed promise in patients with high-risk relapsed/refractory indolent non-Hodgkin lymphoma.

CAR T-Cell Therapy, C-CAR066, Showed Promising Efficacy in R/R B-NHL
June 08, 2021

CAR066, showed a favorable safety profile and promising efficacy in the treatment of adult patients with relapsed/refractory B-cell non-Hodgkin lymphoma who failed prior CD19 CAR T-cell therapy.